Tissue inhibitor of metalloproteinases-1 promotes liver fibrosis development in a transgenic mouse model

Hepatology

Volumn 32, Issue 6, 2000, Pages 1248-1254

  Yoshiji, Hitoshi ^a   Kuriyama, Shigeki ^a   Miyamoto, Yoji ^a   Thorgeirsson, Unnur P ^b   Gomez, Daniel E ^d   Kawata, Mitsuhiro ^a   Yoshii, Junichi ^a   Ikenaka, Yasuhide ^a   Noguchi, Ryuichi ^a   Tsujinoue, Hirohisa ^a   Nakatani, Toshiya ^a   Thorgeirsson, Snorri S ^c   Fukui, Hiroshi ^a  

^a NARA MEDICAL UNIVERSITY   (Japan)

^b Laboratory of Cellular Carcinogenesis and Promotion   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

^d UNIVERSIDAD NACIONAL DE QUILMES   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ACTIN; CHLOROFORM; COLLAGEN TYPE 1; COLLAGEN TYPE 4; GELATINASE A; HYALURONIC ACID; HYDROXYPROLINE; PROCOLLAGEN; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ACTIVATION; CONTROLLED STUDY; DENSITOMETRY; ENZYME INHIBITION; FIBROGENESIS; IMMUNOHISTOCHEMISTRY; LIVER FIBROSIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; TISSUE LEVEL; TRANSGENIC MOUSE;

EID: 0033646761     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhep.2000.20521     Document Type: Article

References (43)

1. Molecular regulation of hepatic fibrogenesis
2. Degradation of matrix proteins in liver fibrosis
3. Metalloproteinases and their inhibitors in matrix remodeling
4. Tissue inhibitors of metalloproteinases: Structure, regulation and biological functions
5. Matrix metalloproteinases and their inhibitors in connective tissue remodeling
6. Tissue inhibitors of metalloproteinases in liver fibrosis
7. Cellular distribution of transcripts for tissue inhibitor of metalloproteinases 1 and 2 in human hepatocellular carcinomas
8. Tissue inhibitors of metalloproteinases, hepatic stellate cells and liver fibrosis
9. Altered balance between matrix metalloproteinases and their inhibitors in experimental biliary fibrosis
10. Expression of tissue inhibitor of metalloproteinases 1 and 2 is increased in fibrotic human liver
11. Tissue inhibitor of metalloproteinase-1 in the liver of patients with chronic liver disease
12. Tissue inhibitor of metalloproteinase-1 messenger RNA expression is enhanced relative to interstitial collagenase messenger RNA in experimental liver injury and fibrosis
13. Tissue inhibitor of metalloproteinase-1 and -2 RNA expression in rat and human liver fibrosis
14. Tissue inhibitor of metalloproteinase-I and interstitial collagenase expression in autoimmune chronic active hepatitis and activated human hepatic lipocytes
15. Increased expression of matrix metalloproteinasein experimental liver fibrosis in rats
16. Serum tissue inhibitor of metalloproteinases in patients with chronic liver disease and with hepatocellular carcinoma
17. Mechanisms of spontaneous resolution of rat liver fibrosis. Hepatic stellate cell apoptosis and reduced hepatic expression of metalloproteinase inhibitors
18. Circulating matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-1 as serum markers of fibrosis in patients with chronic hepatitis C. Relationship to interferon response
19. Differential expression of matrix-metalloproteinase-1 and -2 genes in normal and fibrotic human liver
20. Mammary carcinoma cells over-expressing tissue inhibitor of metalloproteinases-1 show enhanced vascular endothelial growth factor expression
21. An albumin enhancer located 10 kb upstream functions along with its promoter to direct efficient, liver-specific expression in transgenic mice
22. Hepatic expression of mature transforming growth factor beta 1 in transgenic mice results in multiple tissue lesions
23. Quantitative reverse zymography: Analysis of picogram amounts of metalloproteinase inhibitors using gelatinase A and B reverse zymograms
24. Coexpression of C-myc and transforming growth factor alfa in the liver promotes early replicative senescence and diminishes regenerative capacity after partial hepatectomy in transgenic mice
25. Constitutive expression of mature transforming growth factor betal in the liver accelerates hepatocarcinogenesis in transgenic mice
26. Fibrosis accelerates the development of enzyme-altered lesions in the rat liver
27. Molecular cloning and characterization of human tissue inhibitor of metalloproteinase 4
28. Inhibition of vascular and epithelial differentiation in murine nitrofen-induced diaphragmatic hernia
29. Extracellular-matrix gene expression during mouse submandibular gland development
30. Stimulatory effect of endogenous tissue inhibitor of metalloproteinases-1 (TIMP-1) overexpression on type IV collagen and laminin gene expression in rat mammary carcinoma cells
31. Human hepatic lipocytes synthesize tissue inhibitor of metalloproteinases-1. Implications for regulation of matrix degradation in liver
32. Progelatinase A is produced and activated by rat hepatic stellate cells and promotes their proliferation
33. The soluble catalytic domain of membrane type 1 matrix metalloproteinase cleaves the propeptide of progelatinase A and initiates autoproteolytic activation. Regulation by TIMP-2 and TIMP-3
34. Identification of a stimulator of steroid hormone synthesis isolated from testis
35. A fibroblast elongation factor purified from colon carcinoma cells shares sequence identity with TIMP-1
36. A metalloproteinase inhibitor as an inhibitor of neovascularization
37. Breast cancer: Tumor neovasculature and the effect of tissue inhibitor of metalloproteinases-1 (TIMP-1) on angiogenesis
38. In vitro suppression of programmed cell death of B cells by tissue inhibitor of metalloproteinases-1
39. Tissue inhibitor of metalloproteinase-1 inhibits apoptosis of human breast epithelial cells
40. Tissue inhibitor of metalloproteinase (TIMP)-1 induces differentiation and an antiapoptotic phenotype in germinal center B cells
41. Cell cycle-associated accumulation of tissue inhibitor of metallo-proteinases-1 (TIMP-1) in the nuclei of human gingival fibroblasts
42. Tissue inhibitor of metalloproteinases-1 (TIMP-1) binds to the cell surface and translocates to the nucleus of human MCF-7 breast carcinoma cells